Celldex Therapeutics shares owned by Eventide Asset Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Eventide Asset Management
from 13F filings
Historical chart of Eventide Asset Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Eventide Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $113M | 3.3M | 33.99 |
| 2024-06-30 | $123M | 3.3M | 37.01 |
| 2024-03-31 | $131M | 3.1M | 41.97 |
| 2023-12-31 | $144M | 3.6M | 39.66 |
| 2023-09-30 | $44M | 1.6M | 27.52 |
| 2023-06-30 | $47M | 1.4M | 33.93 |
| 2023-03-31 | $50M | 1.4M | 35.98 |
| 2022-12-31 | $65M | 1.5M | 44.57 |
| 2022-09-30 | $50M | 1.8M | 28.11 |
| 2022-06-30 | $39M | 1.4M | 26.96 |
| 2022-03-31 | $49M | 1.4M | 34.06 |
| 2021-12-31 | $48M | 1.2M | 38.64 |
| 2021-09-30 | $61M | 1.1M | 53.99 |
| 2021-06-30 | $71M | 2.1M | 33.44 |
| 2021-03-31 | $43M | 2.1M | 20.60 |
| 2020-12-31 | $32M | 1.8M | 17.52 |
| 2020-09-30 | $7.5M | 506k | 14.83 |
| 2020-06-30 | $6.0M | 463k | 13.00 |